期刊
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
卷 37, 期 6, 页码 1697-1705出版社
SPANDIDOS PUBL LTD
DOI: 10.3892/ijmm.2016.2555
关键词
astragaloside IV; C2C12 myotube; palmitate; insulin resistance; glucose uptake
Astragaloside IV is a monomer isolated from Astragalus membranaceus (Fisch.) Bunge, which is one of the most widely used plant-derived drugs in traditional Chinese medicine for diabetes therapy. In the present study, we aimed to examine the effects of astragaloside IV on glucose in C2C12 myotubes and the underlying molecular mechanisms responsible for these effects. Four-day differentiated C2C12 myotubes were exposed to palmitate for 16 h in order to establish a model of insulin resistance and H-3 glucose uptake, using 2-Deoxy-D-[1,2-H-3(N)]-glucose (radiolabeled 2-DG), was detected. Astragaloside IV was added 2 h prior to palmitate exposure. The translocation of glucose transporter 4 (GLUT4) was evaluated by subcellular fractionation, and the expression of insulin signaling molecules such as insulin receptor (IR), insulin receptor substrate (IRS)1/protein kinase B (AKT) and inhibitory B kinase (IKK)/inhibitor-B (IB), which are associated with insulin signal transduction, were assessed in the basal or the insulin-stimulated state using western blot analysis or RT-PCR. We also examined the mRNA expression of monocyte chemotactic protein 1 (MCP-1), interleukin 6 (IL-6), tumor necrosis factor (TNF) and Toll-like receptor 4 (TLR4). Taken together, these findings demonstrated that astragaloside IV facilitates glucose transport in C2C12 myotubes through a mechanism involving the IRS1/AKT pathway, and suppresses the palmitate-induced activation of the IKK/IB pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据